Latest news articles

Added 7 days ago Drug news

Phase III DECLARE-TIMI 58 results for Farxiga show reduced risk of hospitalisation from CV events.- AstraZeneca.

AstraZeneca announced positive full results from the DECLARE-TIMI 58 cardiovascular (CV) outcomes trial (CVOT) for Farxiga (dapagliflozin) which showed that...

Added 7 days ago Drug news

Phase III ODYSSEY OUTCOMES trial of Praluent shows fewer deaths from CV events-. Sanofi + Regeneron.

New analyses on mortality from the 18,924-patient phase III ODYSSEY OUTCOMES trial of Praluent (alirocumab), from Regeneron, shows it is...

Added 10 days ago Drug news

NEJM publishes positive results from Praluent cardiovascular outcomes trial.- Sanofi + Regeneron

The New England Journal of Medicine (NEJM) published positive detailed results of the 18,924-patient ODYSSEY OUTCOMES trial.The trial met its...

Search all news articles for Cardiac arrest and ventricular fibrillation
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Cardiovascular Metabolism Knowledge Centre

Cardiovascular Metabolism Knowledge Centre

The Cardiovascular Metabolism Knowledge Centre is an information hub providing expert insight into the management of hypertension and type 2 diabetes. This Knowledge Centre contains a wealth of scientific video content offering insights and opinion from some of the leading experts in the field.

ESICM LIVES Highlights

ESICM LIVES Highlights

ESICM LIVES Congress 2018: Bringing you the latest news and insights from the 31st ESICM LIVES Congress, 20–24 October 2018 Paris, France.

Load more

Guidelines

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

In light of the very recent consensus documents for the management of patients with VA released by the major international heart rhythm societies, the ESC Guidelines Committee decided to focus the content of this document on the prevention of SCD.

Added 3 years ago

Search all guidelines for Cardiac arrest and ventricular fibrillation
 

Journal articles

Effect of 0.9% Saline or Plasma-Lyte 148 as Crystalloid Fluid Therapy in the Intensive Care Unit on Blood Product Use and Postoperative Bleeding After Cardiac Surgery

To evaluate the effect of Plasma-Lyte 148 (PL-148) compared with 0.9% saline (saline) on blood product use and postoperative bleeding in patients admitted to the intensive care unit (ICU) following cardiac surgery.

Added 4 months ago

Perioperative Use of Levosimendan Improves Clinical Outcomes in Patients Post-Cardiac Surgery: A Systematic Review and Meta-analysis.

Severe postoperative complications can affect cardiac surgery patients. Levosimendan is a novel calcium sensitizer commonly administered after cardiac surgery.

Added 6 months ago

Prasugrel hydrochloride for the treatment of acute coronary syndromes.

Introduction: P2Y12 receptor antagonists, by inhibiting platelet activation and subsequent aggregation, are critical to prevent ischemic event recurrence after an...

Added 3 years ago

Search all journal articles for Cardiac arrest and ventricular fibrillation
 

CME

Basic life support

Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available
1
Registration required
1
Subscription fee
90
Search all CME for Cardiac arrest and ventricular fibrillation